Literature DB >> 8594216

SjvO2 monitoring in head-injured patients.

C S Robertson1, S P Gopinath, J C Goodman, C F Contant, A B Valadka, R K Narayan.   

Abstract

Jugular venous oxygen saturation (SjvO2) measures the balance between cerebral oxygen delivery and cerebral oxygen consumption. Abnormalities that increase oxygen consumption (e.g., fever or seizures) or that decrease oxygen delivery (e.g., increased ICP, hypotension, hypoxia, hypocapnia, or anemia) can decrease SjvO2. Measuring SjvO2 continuously in the ICU in 177 patients with severe head injury, jugular venous desaturation (SjvO2 < 50%) was identified at least once in 39% of the patients. Approximately half of the episodes of desaturation were due to intracranial hypertension and half were due to systemic causes. The occurrence of one or more episodes of desaturation was strongly associated with a poor outcome, suggesting that the reduction in oxygen delivery identified with the SjvO2 monitoring contributed to the neurological injury. In the operating room, jugular venous desaturation was identified in 6 of 8 patients who were monitored during emergency evacuation of a traumatic intracranial hematoma. The lowest SjvO2 observed was 28%. In all 8 cases, the SjvO2 increased, from 47 +/- 10% to 63 +/- 5% after evacuation of the hematoma. Additional data supporting the hypothesis that these secondary insults identified with the SjvO2 monitoring contribute to the patient's neurological injury come from measurement of the extracellular concentrations of lactate and excitatory amino acids in the brain using microdialysis. Lactate concentration increased from 0.9 +/- 0.3 to 2.4 +/- 0.5 mumol/L and glutamate increased from 11.5 +/- 8.5 to 55.0 +/- 10.4 mumol/L during 8 episodes of jugular venous desaturation in 7 of 22 patients monitored with microdialysis. SjvO2 identifies global reductions in cerebral oxygenation due to a variety of causes, and is useful as a monitor for secondary insults in patients with severe head injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594216     DOI: 10.1089/neu.1995.12.891

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  28 in total

Review 1.  Biomarkers in neurocritical care.

Authors:  W Taylor Kimberly
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Update on multimodality monitoring.

Authors:  Chad M Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

3.  The impact of anemia in moderate to severe traumatic brain injury.

Authors:  O Okoye; K Inaba; M Kennedy; A Salim; P Talving; D Plurad; L Lam; D Demetriades
Journal:  Eur J Trauma Emerg Surg       Date:  2013-06-18       Impact factor: 3.693

Review 4.  Neuromonitoring in neurological critical care.

Authors:  Ian F Dunn; Dilantha B Ellegala; Dong H Kim; Zachary N Litvack
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 5.  Multimodal monitoring and neurocritical care bioinformatics.

Authors:  J Claude Hemphill; Peter Andrews; Michael De Georgia
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 6.  Acute Management of Traumatic Brain Injury.

Authors:  Michael A Vella; Marie L Crandall; Mayur B Patel
Journal:  Surg Clin North Am       Date:  2017-10       Impact factor: 2.741

7.  Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage.

Authors:  Pedro Kurtz; J Michael Schmidt; Jan Claassen; Emmanuel Carrera; Luis Fernandez; Raimund Helbok; Mary Presciutti; R Morgan Stuart; E Sander Connolly; Neeraj Badjatia; Stephan A Mayer; Kiwon Lee
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

Review 8.  Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit.

Authors:  Peter Le Roux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 9.  [Aneurysmal subarachnoid hemorrhage. Significance and complications].

Authors:  A S Sarrafzadeh; U Kaisers; W Boemke
Journal:  Anaesthesist       Date:  2007-09       Impact factor: 1.041

Review 10.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.